Novartis
NVS
#48
Rank
$197.31 B
Marketcap
$91.73
Share price
1.09%
Change (1 day)
13.70%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Earnings for Novartis (NVS)

Earnings in 2022 (TTM): $23.58 B

According to Novartis's latest financial reports the company's current earnings (TTM) are $23.58 B. In 2021 the company made an earning of $26.13 B an increase over its 2020 earnings that were of $9.87 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novartis from 2001 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$23.58 B-9.78%
2021$26.13 B164.6%
2020$9.87 B10.49%
2019$8.94 B-36.79%
2018$14.14 B57.16%
2017$8.99 B15.12%
2016$7.81 B-3.9%
2015$8.13 B-37.17%
2014$12.94 B20.61%
2013$10.73 B-4.52%
2012$11.24 B4.36%
2011$10.77 B-7.94%
2010$11.70 B17.94%
2009$9.92 B4.45%
2008$9.49 B26%
2007$7.53 B-9.18%
2006$8.30 B14.26%
2005$7.26 B5.17%
2004$6.90 B13.84%
2003$6.06 B-38.51%
2002$9.86 B574.04%
2001$1.46 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$22.51 B-4.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$34.92 B 48.10%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.31 B-60.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.65 B-63.30%๐Ÿ‡ซ๐Ÿ‡ท France
$17.77 B-24.62%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.71 B-67.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.38 B-89.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
$6.58 B-72.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$1.34 B-105.65%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel